Robert L. Haining

2.9k total citations · 1 hit paper
28 papers, 2.3k citations indexed

About

Robert L. Haining is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Robert L. Haining has authored 28 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 15 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Robert L. Haining's work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (14 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Robert L. Haining is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (14 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Robert L. Haining collaborates with scholars based in United States, Canada and Australia. Robert L. Haining's co-authors include Allan E. Rettie, Ai‐Ming Yu, William Trager, Mary F. Paine, Darryl C. Zeldin, Ann Hunter, Kirk R. Henne, Maurice E. Veronese, Thomas H. Rushmore and Timothy S. Tracy and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Robert L. Haining

28 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”

2006 639 citations Mary F. Paine, Robert L. Haining et al. Drug Metabolism and Disposition profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert L. Haining	1.7k	856	410	401	282	28	2.3k
A. David Rodrigues	1.8k 1.1×	1.1k 1.3×	619 1.5×	406 1.0×	362 1.3×	68	3.0k
S. Ball	1.5k 0.9×	745 0.9×	599 1.5×	295 0.7×	256 0.9×	28	2.3k
Thomas Kronbach	1.6k 1.0×	929 1.1×	677 1.7×	379 0.9×	421 1.5×	37	2.6k
Ruth Hyland	1.5k 0.9×	734 0.9×	639 1.6×	300 0.7×	289 1.0×	31	2.5k
Toshiro Niwa	1.1k 0.6×	505 0.6×	452 1.1×	258 0.6×	220 0.8×	98	2.2k
Mark VandenBranden	2.4k 1.4×	1.3k 1.6×	615 1.5×	361 0.9×	492 1.7×	28	3.1k
Slobodan Rendić	2.1k 1.3×	972 1.1×	870 2.1×	369 0.9×	229 0.8×	45	3.2k
Lisa L. von Moltke	1.2k 0.7×	596 0.7×	265 0.6×	388 1.0×	296 1.0×	22	2.0k
Regina W. Wang	1.1k 0.6×	646 0.8×	494 1.2×	211 0.5×	220 0.8×	32	1.9k
A. Parkinson	1.2k 0.7×	522 0.6×	564 1.4×	319 0.8×	133 0.5×	56	2.6k

Countries citing papers authored by Robert L. Haining

Since Specialization

Citations

This map shows the geographic impact of Robert L. Haining's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Haining with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Haining more than expected).

Fields of papers citing papers by Robert L. Haining

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Haining. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Haining. The network helps show where Robert L. Haining may publish in the future.

Co-authorship network of co-authors of Robert L. Haining

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Haining. A scholar is included among the top collaborators of Robert L. Haining based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Haining. Robert L. Haining is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haining, Robert L., et al.. (2016). Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy. Neurochemical Research. 41(12). 3356–3363. 7 indexed citations

Russell, James E., et al.. (2015). Bridging the Undergraduate Curriculum Using an Integrated Course-Embedded Undergraduate Research Experience (ICURE). CBE—Life Sciences Education. 14(1). ar4–ar4. 39 indexed citations

Haining, Robert L., et al.. (2008). Expression and Functional Analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 Isozymes. Drug Metabolism and Disposition. 37(1). 1–4. 25 indexed citations

Paine, Mary F., et al.. (2006). THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”. Drug Metabolism and Disposition. 34(5). 880–886. 639 indexed citations breakdown →

Yu, Ai‐Ming & Robert L. Haining. (2006). EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF MOUSE CYP2D22. Drug Metabolism and Disposition. 34(7). 1167–1174. 22 indexed citations

Haining, Robert L., et al.. (2006). Cytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?. Pharmacology & Therapeutics. 113(3). 537–545. 26 indexed citations

Haining, Robert L., et al.. (2005). CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: Kinetics, pharmacogenetics and interaction with phenytoin. Biochemical Pharmacology. 70(7). 1096–1103. 78 indexed citations

Hummel, Matthew A., Leslie J. Dickmann, Allan E. Rettie, Robert L. Haining, & Timothy S. Tracy. (2004). Differential activation of CYP2C9 variants by dapsone. Biochemical Pharmacology. 67(10). 1831–1841. 26 indexed citations

Yu, Ai‐Ming, Camille Granvil, Robert L. Haining, et al.. (2003). The Relative Contribution of Monoamine Oxidase and Cytochrome P450 Isozymes to the Metabolic Deamination of the Trace Amine Tryptamine. Journal of Pharmacology and Experimental Therapeutics. 304(2). 539–546. 43 indexed citations

10.

Yu, Ai‐Ming, et al.. (2002). Expression, Purification, Biochemical Characterization, and Comparative Function of Human Cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 Allelic Isoforms. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1291–1300. 82 indexed citations

11.

Tracy, Timothy S., J. Matthew Hutzler, Robert L. Haining, et al.. (2002). Polymorphic Variants (CYP2C9*3 and CYP2C9*5) and the F114L Active Site Mutation of CYP2C9: Effect on Atypical Kinetic Metabolism Profiles. Drug Metabolism and Disposition. 30(4). 385–390. 72 indexed citations

12.

Yu, Ai‐Ming, et al.. (2002). Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro. Biochemical Pharmacology. 63(12). 2111–2119. 57 indexed citations

13.

Suzuki, Hisashi, M. Byron Kneller, Robert L. Haining, William Trager, & Allan E. Rettie. (2002). (+)-N-3-Benzyl-Nirvanol and (−)-N-3-Benzyl-Phenobarbital: New Potent and Selective in Vitro Inhibitors of CYP2C19. Drug Metabolism and Disposition. 30(3). 235–239. 82 indexed citations

14.

Yu, Ai‐Ming & Robert L. Haining. (2001). Purification, Biochemical Characterization and Comparative Enzyme Kinetics of Recombinant Human CYP2D6 1 and CYP2D6 2 Variants. Advances in experimental medicine and biology. 500. 327–330. 1 indexed citations

15.

Yu, Ai‐Ming & Robert L. Haining. (2001). Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?. PubMed. 29(11). 1514–20. 123 indexed citations

16.

Kilicarslan, Tansel, et al.. (2001). Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4.. PubMed. 29(4 Pt 1). 460–5. 31 indexed citations

17.

Rettie, Allan E., Robert L. Haining, Manoj Bajpai, & René H. Levy. (1999). A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin. Epilepsy Research. 35(3). 253–255. 86 indexed citations

18.

Haining, Robert L., Kirk R. Henne, George Davis, et al.. (1997). Genetic association between sensitivity to warfarin and expression of CYP2C9*3. Pharmacogenetics. 7(5). 361–367. 239 indexed citations

19.

Tugnait, Meera, et al.. (1997). N-oxygenation of clozapine by flavin-containing monooxygenase.. PubMed. 25(4). 524–7. 59 indexed citations

20.

Haining, Robert L., Ann Hunter, Maurice E. Veronese, William Trager, & Allan E. Rettie. (1996). Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant Forms. Archives of Biochemistry and Biophysics. 333(2). 447–458. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact